Colgate-Palmolive stock holds above $90 as Q2 2026 earnings top expectations
Published on 08/31/2026 at 20:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Colgate-Palmolive Inc. (ISIN US1941621039) stock is trading in the low-$90s region as of August 31, 2026, after the household and personal care group delivered second-quarter 2026 earnings that modestly beat profit expectations while posting steady sales growth.
Per recent market data as of August 31, 2026, Colgate-Palmolive shares opened at $90.75 in the latest New York session, giving the company a valuation in line with broader consumer staples peers.
In its most recent reporting period for the second quarter of 2026, Colgate-Palmolive generated revenue of $5.36 billion, representing a 4.9 percent increase compared with the same quarter a year earlier, while earnings per share of $0.99 came in ahead of the $0.95 consensus forecast.
This combination of mid-single-digit top-line growth and a modest earnings beat has helped underpin a generally constructive analyst view, with the current average 12-month price objective set at $99, which stands above the recent $90.75 trading level and signals scope for upside if execution remains on track.
Q2 2026 results show balanced growth in sales and earnings
The Q2 2026 numbers provide a useful snapshot of Colgate-Palmolive's operating momentum at a time when consumer spending patterns are still adjusting to prior price increases in everyday goods.
Revenue for the quarter came in at $5.36 billion, up 4.9 percent year over year, indicating that the company is still able to grow its top line despite a mature portfolio and intense competition in oral care, personal care, and home care categories.
On the profit side, Colgate-Palmolive reported quarterly earnings per share of $0.99, exceeding the consensus expectation of $0.95 by $0.04, or just over 4 percent, which points to disciplined cost management and some operating leverage on incremental sales.
Organic sales growth - which strips out currency effects and acquisitions - was reported at 2.4 percent in the second quarter of 2026, suggesting that the bulk of the 4.9 percent total revenue increase was driven by favorable foreign exchange and mix, even as underlying volume and pricing delivered a more modest advance.
Management highlighted 8 percent base-business EPS growth in the quarter, which compares the recurring profit from ongoing operations against the prior-year baseline and underscores that the earnings improvement was not solely due to one-off items or financial engineering.
For investors, this combination of 2.4 percent organic sales growth and 8 percent base-business EPS growth in Q2 2026 signals that Colgate-Palmolive is navigating inflation and input cost pressures with a tilt toward margin preservation, even if volume growth remains limited in some categories.
Market view and valuation context for Colgate-Palmolive stock
Analyst sentiment toward Colgate-Palmolive is broadly constructive heading into the second half of 2026, reflecting the company's steady earnings profile and strong brands in oral care and home care.
Across the latest compiled research, Colgate-Palmolive currently holds a consensus rating described as a moderate buy, with 12 analysts assigning a buy recommendation and seven offering a hold stance, indicating a slight majority favoring incremental exposure at current levels.
The average price target from this coverage stands at $99 per share, with individual targets spanning from $90 to $110, placing the current $90.75 opening price for the latest session below the midpoint of that range and modestly under the average target.
This implies that Colgate-Palmolive stock trades at a discount of just over 8 percent relative to the $99 average objective, a gap that could close if the company extends its record of EPS beats and maintains positive organic sales growth through the remainder of fiscal 2026.
Technical measures also reflect a relatively steady trading profile: the stock's 50-day moving average price is reported at $92.02, while the 200-day moving average stands at $90.03, suggesting that the present $90.75 level sits between these trend indicators and does not represent an extreme overextension in either direction.
From a medium-term perspective, the fact that the current price is slightly above the 200-day moving average but below the 50-day moving average can be interpreted as a consolidation phase, where the stock digests prior gains while investors reassess valuation against earnings momentum and sector peers.
With consumer staples equities often prized for their defensiveness and dividend reliability rather than rapid capital appreciation, the moderate upside implied by the $99 average target and the ongoing delivery of positive EPS surprises form a key part of the thesis for investors who value predictability in cash flows.
Analyst and investor positioning highlighted by recent filings
Recent institutional activity provides further insight into how professional investors view Colgate-Palmolive as of late August 2026, complementing the picture offered by the consensus rating and price targets.
In one recently reported holding disclosure, a quantitative-focused investment manager was shown to hold stock positions valued at $138,000 in Colgate-Palmolive, underlining continued interest from systematic strategies that seek exposure to companies with stable fundamental profiles and liquidity.
Another filing highlighted a separate investor buying 107,227 shares in Colgate-Palmolive, adding a meaningful stake that reflects conviction in the company's long-term earnings and dividend trajectory despite the relatively modest near-term growth outlook.
These kinds of incremental institutional allocations, while not transformational in isolation, contribute to a supportive shareholder base that can help stabilize the share price during broader market volatility.
For existing shareholders, the mix of buy and hold ratings, the moderate buy consensus, and fresh institutional buying activity together signal that Colgate-Palmolive remains a core holding in many defensive and income-oriented portfolios.
At the same time, the absence of a strong sell skew in ratings suggests that few analysts expect material downside from current levels, provided that management continues to deliver on organic growth and base-business EPS progression.
Core product focus: Colgate toothpaste as a global oral care anchor
Colgate-Palmolive's long-term growth and resilience are closely tied to its flagship Colgate toothpaste franchise, which sits at the center of the company's oral care segment and acts as a gateway brand in many households worldwide.
The Colgate toothpaste range spans whitening variants, cavity protection formulas, sensitivity relief options, and products targeted at gum health, giving the company a broad portfolio that can be tailored to different consumer needs and price points.
In many markets, Colgate-branded toothpaste holds leading shelf share and brand recognition, which supports pricing power and helps the company pass through cost inflation in packaging and raw materials without fully sacrificing volume.
From a strategic perspective, maintaining category leadership in toothpaste is crucial for cross-selling other oral care products such as toothbrushes, mouthwash, and specialty solutions for dentists, extending the revenue base beyond the core tube product.
As Colgate-Palmolive continues to invest in research and development for oral care, including enamel-strengthening technologies and stain-removal chemistry, the toothpaste franchise remains a centerpiece for innovation and marketing campaigns.
For investors, the strength of the Colgate toothpaste brand forms a key intangible asset underpinning the valuation of Colgate-Palmolive stock, as it supports recurring revenue streams and loyal customer behavior that can smooth earnings across economic cycles.
Colgate-Palmolive stock price snapshot and investor takeaway
Colgate-Palmolive shares trade on the New York Stock Exchange under the ticker CL, using the US dollar as their core currency for quotations and settlements.
As of the latest available trading data for August 31, 2026, Colgate-Palmolive stock opened at $90.75, compared with a 50-day moving average price of $92.02 and a 200-day moving average of $90.03, placing the current level slightly above the long-term trend line but modestly below the shorter-term average.
In practical terms, this positioning means the stock is neither at a multi-year extreme nor at a fresh high, and instead reflects a steady trading band consistent with its role as a defensive consumer staples name.
For retail investors, the key numbers now are the 2.4 percent organic sales growth and 8 percent base-business EPS growth reported in Q2 2026, the $0.99 EPS versus the $0.95 consensus for that quarter, and the $99 average analyst price target relative to the recent $90.75 price.
Together, these figures indicate that Colgate-Palmolive is delivering modest growth and consistent earnings beats while trading at a level that still offers numerical headroom to the average target, which may appeal to those prioritizing stability and incremental capital appreciation over aggressive growth.
Read more
More on Colgate-Palmolive stock and its latest institutional ownership trends can be found in the detailed filing overview at this recent holdings summary.
Colgate oral care portfolio and innovation
Beyond the core toothpaste line, Colgate-Palmolive's oral care portfolio includes manual and electric toothbrushes, mouth rinses, and specialty products designed for orthodontic and pediatric care.
In many regions, the company extends the Colgate brand into premium tiers that offer enhanced whitening, advanced stain-removal technology, or targeted gum health solutions, catering to consumers willing to pay higher prices for visible benefits and clinical claims.
Innovation cycles in oral care often feature new formulations that reduce sensitivity, strengthen enamel, or deliver faster whitening, and Colgate-Palmolive invests in clinical studies and dentist partnerships to support these product launches.
Digital engagement, including educational content on oral hygiene and interactive tools to track brushing habits, has become an increasingly important complement to traditional advertising, helping the company deepen relationships with consumers who seek personalized guidance.
As health-conscious behavior continues to gain traction globally, Colgate-Palmolive's focus on oral care science and brand trust positions it well to capture incremental demand, reinforcing the earnings stream that underlies Colgate-Palmolive stock.
Fact box: Colgate-Palmolive stock and key data
Company: Colgate-Palmolive Inc.
ISIN: US1941621039
Ticker: CL
Exchange: New York Stock Exchange
Sector / Industry: Consumer staples - household and personal care
Index membership: S&P 500
Price (as of August 31, 2026, latest opening data): $90.75 USD
50-day moving average price: $92.02 USD
200-day moving average price: $90.03 USD
